Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F20TP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,054
Award facts
- Contract value 100% obligated
- $37,053.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 14, 2026, requires Amerisourcebergen Drug Corp to supply RINVOQ ER 15 MG tablets (30-count units) to the Defense Logistics Agency with a ceiling value of $37,053.86 and a firm fixed price structure. The award is non-competitive and represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of brand-name and generic medications, vaccines, and medical supplies to military healthcare systems worldwide. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026.
RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for treating rheumatoid arthritis and other inflammatory conditions, making this order part of DLA's ongoing procurement of specialty pharmaceuticals for military medical treatment facilities and veteran healthcare programs. As a non-set-aside award, this order reflects Cencora/Amerisourcebergen's established capability to efficiently fulfill federal pharmaceutical requirements through its existing contract vehicle. The expedited completion timeline of one day suggests this is a critical resupply order for an active military medical facility or healthcare system.
Quick answers
Who was awarded contract SPE2DR26F20TP?
SPE2DR26F20TP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F20TP worth?
The government has obligated $37,054 on SPE2DR26F20TP.
Is contract SPE2DR26F20TP an order under another contract?
Yes. SPE2DR26F20TP is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20TP competed?
The extent of competition for SPE2DR26F20TP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award